Ademetionine (S-adenosylmethionine) neuropharmacology: implications for drug therapies in psychiatric and neurological disorders

By Bottiglieri T.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 4, 1997-04 ,pp. : 417-426

Informa Healthcare

Access to resources Recommend Favorite

Cyclosporin-Induced Hypertension: Incidence, Pathogenesis and Management

By Taler S.J.   Textor S.C.   Canzanello V.J.   Schwartz L.  

Drug Safety, Vol. 20, Iss. 5, 1999-05 ,pp. : 437-449

Adis International

Access to resources Recommend Favorite

Antileishmanial Effect of a Potent S-Adenosylmethionine Decarboxylase Inhibitor: Cgp 40215a

By Mukhopadhyay R.   Kapoor P.   Madhubala R.  

Pharmacological Research, Vol. 33, Iss. 1, 1996-01 ,pp. : 67-70

Academic Press

Access to resources Recommend Favorite

Inhibition mechanism of S-adenosylmethionine-induced movement deficits by prenylcysteine analogs

By Lamango N.S.   Ayuk-Takem L.T.   Nesby R.   Zhao W.-Q.   Charlton C.G.  

Pharmacology Biochemistry and Behavior, Vol. 76, Iss. 3, 2003-12 ,pp. : 433-442

Elsevier

Access to resources Recommend Favorite

Drug-induced cholestasis

By Velayudham Lakshumanan S   Farrell Geoffrey C  

Expert Opinion on Drug Safety, Vol. 2, Iss. 3, 2003-05 ,pp. : 287-304

Informa Healthcare

Access to resources Recommend Favorite